Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Stanford gene therapy eases multiple sclerosis symptoms in mice

April 29, 1998

Pierre Fabre synthesizes sumatriptan dimer with improved 5-HT1B/1D-agonist effects

April 29, 1998

Eletriptan for migraine during menstruation

April 28, 1998

Activa Parkinson's Control therapy receives CE Mark approval; European introduction announced

April 28, 1998

Astra's 3-HAO inhibitor NCR-631 demonstrates neuroprotective potential

April 28, 1998

Ionotropic glutamate receptor ligands for neurological and CNS disorders

April 28, 1998

Substance P antagonists from Pfizer especially useful for pain, inflammation

April 28, 1998

Synthetic, nonandrogenic DHEA active in animal model of MS

April 28, 1998

New NK1 receptor antagonist ineffective against postherpetic neuralgia

April 27, 1998

Novo Nordisk sells Seroxat marketing rights to SKB

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...